• Research and Development

    Shaping the
    future of medicine
    Start »

11/20/15, Research and Development Bayer’s new five-year-contraceptive submitted for EU and US Marketing Authorization Clinical studies demonstrated efficacy of new long-acting contraceptive with lowest available daily hormone dose for five years of contraception more

11/06/15, Research and Development Latest Clinical Data of Vericiguat To Be Presented at Late-Breaking-Clinical-Trial Session at AHA SOCRATES-REDUCED Phase IIb study results of vericiguat in patients with worsening chronic heart failure and reduced ejection fraction (HFrEF) more

At a glance


Research expenses 2014 EUR 1,878 million
In percent of division sales 2014
Main research sites Berlin and Wuppertal, Germany and Berkeley, USA
Research focus
  • Berlin:
    oncology, women's healthcare
  • Wuppertal:
    Cardiology, oncology
  • Berkeley:
    Applied research and life cycle management in hemophilia and multiple sclerosis


Image: Research and Development

Promising pipeline ensures mid- and long-term innovation

Bayer HealthCare Pharmaceuticals concentrates its R&D activities on innovative treatment alternatives for diseases with a high unmet medical need to improve patients’ quality of life and prolong lives. The focus is on therapeutic areas with a high medical need, where more innovations are needed despite considerable progress.

We hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.

Image: Clinical trials

About Clinical Trials

Clinical trials are used to evaluate potential treatments that have had some effect against disease in the lab, or in animal experiments. The whole point of a clinical trial is to find out if a treatment is effective.

Until sufficient results are available from many different trials it is just that, potential. Effectiveness of a treatment should never be at the expense of safety; the benefit of a treatment should always outweigh the harm and is fundamental to the conduct of all clinical trials.

Page tools
Interactive tool
Grants for Targets
Clinical Trials


Copyright © Bayer Pharma AG